Diagnosis and Management in Otolaryngology 2024

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".

Deadline for manuscript submissions: 31 October 2024 | Viewed by 337

Special Issue Editor


E-Mail Website
Guest Editor
Departments of Otolaryngology, Taichung Veterans General Hospital, Taichung 40705, Taiwan
Interests: allergic rhinitis; chronic rhinosinusitis; endoscopic sinus surgery; gustatory disorders; nasopharyngeal carcinoma; olfactory disorders

Special Issue Information

Dear Colleagues,

Recently, the field of otolaryngology has expanded rapidly. For example, olfactory and gustatory dysfunction has gained considerable attention in the era of COVID-19 outbreak. Biologics have been introduced to treat type 2 chronic rhinosinusitis with nasal polyps. The diagnosis and management of Eustachian tube dysfunction have also been widely investigated. Robotic surgery has become a new tool used to treat head and neck disorders. Despite the rapid progress of medicine, some disorders remain complex and have a significant impact on the global economy in the modern era. Therefore, the early detection and proper management of ear, nose, and throat disorders deserve further attention. Advances in timely diagnosis and proper management would provide practical information about precise prognosis and likely responses to medical or surgical therapy and are therefore pivotal.

On account of the great advances in the molecular and pathophysiological mechanisms of ear, nose, and throat disorders, the relevance of developments for diagnosis and management has attracted a great deal of attention. This Special Issue will address current advances in the diagnosis and management of ear, nose, and throat disorders.

We welcome you to submit original research articles or comprehensive reviews related to all fields of otolaryngology to this Special Issue.

Dr. Rong-San Jiang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • ear
  • diagnosis
  • head and neck
  • management
  • nose
  • otolaryngology
  • throat

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

12 pages, 1192 KiB  
Article
Comparative Efficacy of Different Therapeutic Interventions in Eustachian Tube Dysfunctions: A Cross-Sectional Analysis
by Sarah Alshehri and Abdullah Musleh
Diagnostics 2024, 14(12), 1229; https://doi.org/10.3390/diagnostics14121229 - 12 Jun 2024
Viewed by 234
Abstract
Eustachian tube dysfunction (ETD) affects a significant portion of the population, manifesting symptoms that impact the quality of life. Despite the prevalence of ETD, there remains a notable gap in comprehensive studies exploring the condition’s dynamics within specific demographic contexts, particularly within Saudi [...] Read more.
Eustachian tube dysfunction (ETD) affects a significant portion of the population, manifesting symptoms that impact the quality of life. Despite the prevalence of ETD, there remains a notable gap in comprehensive studies exploring the condition’s dynamics within specific demographic contexts, particularly within Saudi Arabia. This study aimed to assess the prevalence and severity of ETD across different demographic groups, to evaluate the efficacy of various treatment modalities, and to identify key predictors of treatment response in a Saudi Arabian cohort. A cross-sectional study was conducted from June 2022 to May 2023 in tertiary care hospitals in the Aseer region, Saudi Arabia. Participants included adults diagnosed with ETD, assessed through clinical symptoms, otoscopic examinations, audiometric evaluations, tympanometry, and the ETDQ-7 questionnaire. The study incorporated advanced diagnostics such as nasopharyngoscopy and pressure equalization tube function tests and involved 154 participants, revealing significant variations in ETD severity, with the 46–60 age group exhibiting the highest mean ETDQ-7 score of 4.85, and urban residents displaying lower severity scores compared to rural counterparts. Pharmacological interventions were most effective, achieving the highest symptom relief and audiological improvement rates of 87.78%. Multivariate regression highlighted age, geographic location, and treatment modality as key predictors of treatment efficacy, with notable interaction effects between climate conditions and treatment types influencing outcomes. The findings underscore the heterogeneity in ETD presentation and the differential efficacy of treatment modalities. Full article
(This article belongs to the Special Issue Diagnosis and Management in Otolaryngology 2024)
Show Figures

Figure 1

Back to TopTop